Evidence map›Paper›PMID 35796405›Full record

ArticleJournal of computational chemistry2022

Imidazole and nitroimidazole derivatives as NADH-fumarate reductase inhibitors: Density functional theory studies, homology modeling, and molecular docking.

Linda Campos-Fernández, Rocío Ortiz-Muñiz, Edith Cortés-Barberena, Sergio Mares-Sámano, Ramón Garduño-Juárez, Catalina Soriano-Correa

Open access · greenAbstract read
In one paragraph

Article in Journal of computational chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Linda Campos-FernándezDoctorado en Biología Experimental, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City, Iztapalapa, Mexico.
Rocío Ortiz-MuñizDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City, Iztapalapa, Mexico.
Edith Cortés-BarberenaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana-Iztapalapa, Mexico City, Iztapalapa, Mexico.
Sergio Mares-SámanoCONACYT-Instituto de Ciencias Físicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.
Ramón Garduño-JuárezInstituto de Ciencias Físicas, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico.
Catalina Soriano-CorreaUnidad de Química Computacional, Facultad de Estudios Superiores Zaragoza, Universidad Nacional Autónoma de México, Mexico City, Iztapalapa, Mexico.ORCID 0000-0003-3366-9387
Universidad Autónoma Metropolitana · MXUniversidad Nacional Autónoma de México · MXSecretaría de Ciencia, Humanidades, Tecnología e Innovación · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease is caused by Trypanosoma cruzi. Benznidazole and nifurtimox are drugs used for its therapy; nevertheless, they have collateral effects. NADH-fumarate (FUM) reductase is a potential pharmacological target since it is essential for survival of parasite and is not found in humans. The objectives are to design and characterize the electronic structure of imidazole and nitroimidazole derivatives at DFT-M06-2X level in aqueous solution; also, to model the NADH-FUM reductase and analyze its intermolecular interactions by molecular docking. Quantum-chemical descriptors allowed to select the molecules with the best physicochemical properties and lowest toxicity. A high-quality three-dimensional structure of NADH-FUM reductase was obtained by homology modeling. Water molecules do not have influence in the interaction between FUM and NADH-FUM reductase. The main hydrogen-binding interactions for FUM were identified in NADH, Lys172, and Arg89; while hydrophobic interactions in Phe479, Thr174, Met63. The molecules S3-8, S2-8, and S1-8 could be inhibitors of NADH-FUM reductase.

Indexed as

NitroimidazolesOxidoreductases Acting on CH-CH Group DonorsDensity Functional TheoryEnzyme InhibitorsHumansImidazolesMolecular Docking SimulationNADEnzyme Inhibitorsfumarate reductase (NADH)ImidazolesNADNitroimidazolesOxidoreductases Acting on CH-CH Group DonorsChagas diseaseDFT calculationshomology modelingmolecular dockingNADH-fumarate reductase

Identifiers

PMID35796405
PMCPMC9541967
OpenAlexW4284880829

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.